442 related articles for article (PubMed ID: 24919928)
1. The association of -330 interleukin-2 gene polymorphism and HLA-DR15 allele in Iranian patients with multiple sclerosis.
Sayad A
Int J Immunogenet; 2014 Aug; 41(4):330-4. PubMed ID: 24919928
[TBL] [Abstract][Full Text] [Related]
2. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
[TBL] [Abstract][Full Text] [Related]
3. Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis.
Shahbazi M; Roshandel D; Omidnyia E; Rshaidbaghan A
Clin Immunol; 2011 Jun; 139(3):277-81. PubMed ID: 21396892
[TBL] [Abstract][Full Text] [Related]
4. High frequency of the IL-2 -330 T/HLA-DRB1*1501 haplotype in patients with multiple sclerosis.
Shahbazi M; Roshandel D; Ebadi H; Fathi D; Zamani M; Boghaee M; Mohammadhoseeeni M; Rshaidbaghan A; Bakhshandeh A; Shahbazi S
Clin Immunol; 2010 Oct; 137(1):134-8. PubMed ID: 20594918
[TBL] [Abstract][Full Text] [Related]
5. Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis.
Nejati P; Attar M; Rahimian M; Fathi D; Shahbazi M
Iran J Immunol; 2017 Sep; 14(3):231-239. PubMed ID: 28919586
[TBL] [Abstract][Full Text] [Related]
6. Are IL2 promoter polymorphisms associated with MS in Iranian patients? - We do not know.
Jabalameli MR; Zahednasab H
Int J Immunogenet; 2014 Dec; 41(6):528-9. PubMed ID: 25399512
[No Abstract] [Full Text] [Related]
7. Genetic factors and multiple sclerosis in the Moroccan population: a role for HLA class II.
Ouadghiri S; El Alaoui Toussi K; Brick C; Ait Benhaddou EH; Benseffaj N; Benomar A; El Yahyaoui M; Essakalli M
Pathol Biol (Paris); 2013 Dec; 61(6):259-63. PubMed ID: 23849771
[TBL] [Abstract][Full Text] [Related]
8. The +190 G/A (rs1799864) polymorphism in the C-C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1*15:01-negative individuals.
Javor J; Párnická Z; Michalik J; Čopíková-Cudráková D; Shawkatová I; Ďurmanová V; Gmitterová K; Klímová E; Bucová M; Buc M
J Neurol Sci; 2015 Feb; 349(1-2):138-42. PubMed ID: 25604634
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosis.
Rafiei M; Zarif Yeganeh M; Sheikholeslami S; Gozalpour E; Ghaffarpour M; Hedayati M
J Neurol Sci; 2012 Sep; 320(1-2):22-5. PubMed ID: 22698480
[TBL] [Abstract][Full Text] [Related]
10. Combination of interleukin-10 gene promoter polymorphisms with HLA-DRB1*15 allele is associated with multiple sclerosis.
Shahbazi M; Abadi JSA; Roshandel D; Koochaki M; Amiri H; Kohansal R; Baghbanian SM; Zamani M
Indian J Med Res; 2017 Jun; 145(6):746-752. PubMed ID: 29067976
[TBL] [Abstract][Full Text] [Related]
11. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
[TBL] [Abstract][Full Text] [Related]
12. The association of -475 and -631 interleukin-2 gene polymorphism with multiple sclerosis in Iranian patients.
Sayad A; Allameh A; Sayad A; Noruzinia M; Akbari MT; Sarzaeem A; Akbar A; Haji Hoseini R
Cell J; 2013; 15(2):124-9. PubMed ID: 23862113
[TBL] [Abstract][Full Text] [Related]
13. [The study on relation of HLA-DRB1 gene polymorphism to Keshan disease and its association and linkage in the core families].
Wei J; Niu XL; Dong X; Wang YP; Zhu JH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):91-3. PubMed ID: 17285554
[TBL] [Abstract][Full Text] [Related]
14. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
15. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.
Wu JS; James I; Wei Qiu ; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
Mult Scler; 2010 May; 16(5):526-32. PubMed ID: 20207784
[TBL] [Abstract][Full Text] [Related]
16. [Association of HLA-DRB1 and -DPB1 allele polymorphism with multiple sclerosis in Chinese Han population from Southern areas].
Wu XM; Zhang KN; Wang CD; Xiong YQ; Liu Z; Qu XH; Xie XF
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2741-4. PubMed ID: 18167262
[TBL] [Abstract][Full Text] [Related]
17. Association of CD1A +622 T/C, +737 G/C and CD1E +6129 A/G genes polymorphisms with multiple sclerosis.
Jamshidian A; Nikseresht AR; Vessal M; Kamali-Sarvestani E
Immunol Invest; 2010; 39(8):874-89. PubMed ID: 20954848
[TBL] [Abstract][Full Text] [Related]
18. Association of HLA class II alleles and CTLA-4 polymorphism with type 1 diabetes.
Ei Wafai RJ; Chmaisse HN; Makki RF; Fakhoury H
Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):273-81. PubMed ID: 21422625
[TBL] [Abstract][Full Text] [Related]
19. A NOTCH4 missense mutation confers resistance to multiple sclerosis in Japanese.
Huang J; Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Sato S; Yamasaki R; Kira J;
Mult Scler; 2013 Nov; 19(13):1696-703. PubMed ID: 23549433
[TBL] [Abstract][Full Text] [Related]
20. Effects of the multiple sclerosis associated -330 promoter polymorphism in IL2 allelic expression.
Matesanz F; Fedetz M; Leyva L; Delgado C; Fernández O; Alcina A
J Neuroimmunol; 2004 Mar; 148(1-2):212-7. PubMed ID: 14975604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
